Quantcast
Last updated on April 17, 2014 at 15:21 EDT

Latest MS Stories

2013-07-30 08:29:10

NEW YORK, July 30, 2013 /PRNewswire-USNewswire/ -- A research team lead by Violaine Harris, Ph.D., at the Tisch MS Research Center of New York, has just published findings on a new method of measuring disease activity in patients with multiple sclerosis (MS) (Harris, et al, Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis, Multiple Sclerosis Journal, Epub: 2/25/2013 doi: 10.1177/1352458513477923 ahead of print). This important biomarker discovery is based on...

2013-07-25 16:20:52

End Solution Will Leverage the Company's Broad Technology Portfolio and Capabilities ALISO VIEJO, Calif., July 25, 2013 /PRNewswire/ -- Microsemi Corporation (Nasdaq: MSCC), a leading provider of semiconductor solutions differentiated by power, security, reliability and performance, today announced it has been awarded a development contract from the U.S. government to deliver a complex SoC solution. The company currently expects the contract to generate revenue immediately and over...

2013-07-23 13:19:38

But there may be some benefit to those at the lower end of the disability scale The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS), shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale. The study is published in The Lancet Neurology. The CUPID...

2013-07-14 23:00:54

Transparency Market Research add new "Multiple Sclerosis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018" market research report to its report store. Browse the report: visit http://www.transparencymarketresearch.com/multiple-sclerosis-drugs.html Albany, New York (PRWEB) July 14, 2013 Multiple sclerosis (MS) is an inflammation of fatty myelin sheaths around the axons of the brain and spinal cord. MS tends to affect the ability of...

2013-07-14 23:00:39

http://www.SclerosisTreatment.com reviews Gary Levin's Natural Multiple Sclerosis treatment book, a new multiple sclerosis treatment manual that reveals to people causes of MS, symptoms, signs, natural treatments and prevention. Denver, Colorado (PRWEB) July 14, 2013 http://www.SclerosisTreatment.com Exposes Dr. Gary M. Levin's Multiple Sclerosis Treatment Book, a step-by-step method that rehabilitates the immune system and boosts the supporting body systems to eliminate all MS...

2013-07-13 23:03:21

Natural Multiple Sclerosis Treatment created by Gary Levin is a new multiple sclerosis treatment book that reveals to people causes their MS, symptoms, signs, treatments and prevention. A full Natural Multiple Sclerosis Treatment overview on the site Vkool.com indicates if the book is worth buying. Seattle, Wa (PRWEB) July 13, 2013 Natural Multiple Sclerosis Treatment book introduces to people an effective multiple sclerosis treatment, tips, safe methods, natural remedies, diet plans, and...

2013-07-12 23:36:26

MSology, a free news service for people affected by multiple sclerosis (MS), is marking its first anniversary online with the launch of a new library of MS research. Montreal, Quebec (PRWEB) July 11, 2013 In its first year of operation, MSology (http://www.msology.ca) has greeted over 30,000 visitors from 181 countries. While articles are written in English, readers around the world are able to access the information with their search engine’s translation service. “There’s a...

2013-07-12 23:23:33

VITEK® MS innovative system reduces the time to detect microbial contaminants from days to minutes, adding a never-before possible level of safety in the production of many consumer goods St. Louis, MO (PRWEB) July 11, 2013 bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce it has joined with Ultimate Labs, a leader in the safe production and quality control of food, drugs, and medical devices, to provide the industry with VITEK® MS -...

2013-07-11 12:28:08

AMSTERDAM, CAMBRIDGE, England and CLINTON, New Jersey, July 11, 2013 /PRNewswire/ -- Echo Pharmaceuticals ("Echo") announces that Namisol(R) has completed successfully a Phase II trial with 24 patients suffering from spasticity and pain due to multiple sclerosis (MS). The trial has been conducted by the Centre for Human Drug Research (CHDR) in the VU University Medical Center Amsterdam and it was led by Dr. G.J. Groeneveld, Research Director Neurology & Pain, CHDR. The...

2013-07-11 08:29:51

Tecfidera's High Early Physician Trial Rate Surpasses that Observed With Novartis's Gilenya and Genzyme's Aubagio, According to a New Report from BioTrends Research Group EXTON, Pa., July 11, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, despite being the third oral disease-modifying therapy (DMT) to launch in the U.S. multiple sclerosis (MS) market, 53 percent of surveyed...